Abstract:Abstract Background and Aims Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and some glucagon-like-1 receptor agonists (GLP1-RA) have demonstrated to delay diabetic nephropathy (DN) progression. Potentially, the combination of these two therapeutic approaches on top of the standard of care with renin angiotensin system (RAS) blockers could exert additive cardiorenal protection in the diabetic milieu. The present study aimed to evaluate the cardiorenal protective effects of the combination of SGLT2i and GLP1-RA on top of RAS blockade versus the monotherapies on top of RAS blockade in experimental diabetes. Method Twelve weeks old male and female uninefrectomized (UNx) db/db mice were treated for 8 weeks with an SGLT2i (empagliflozin, 10 mg/Kg/day five days a week) and/or a GLP1-RA (semaglutide, 10.0 nmol/kg twice per week) on top of a RAS blocker (ramipril, 8 mg/Kg/day). Vehicle-treated UNx db/db and non-diabetic (db/m) mice were included as controls. During the experiment weight, food and water intake, blood glucose, blood pressure (BP) and glomerular filtration rate (GFR) were measured. Kidney and heart were collected at the end of the experiment. Results The vehicle-treated UNx db/db showed increased body weight, food and water intake and blood glucose as compared to the vehicle-treated UNx db/m (Fig. 1A, B and C, p = 0.03, p<0.001 and p<0.0001, respectively). The GFR slope (ΔGFR, difference between final and basal GFR) was also significantly higher in the vehicle-treated UNx db/db vs the vehicle-treated UNx db/m (Fig. 1D, p = 0.02), a typical feature of incipient DN. All treatments significantly decreased systolic and diastolic BP as compared to vehicle-treated UNx db/db due to its ramipril component (Fig. 1E). Further, both empagliflozin and semaglutide (alone or combined) on top of ramipril lowered blood glucose in UNx db/db (Fig. 1C, p<0.001 vs vehicle UNx db/db in all cases) but semaglutide component maximized this effect. Food and water intake was decreased in UNx db/db treated with semaglutide on top of RAS blockade (alone or combined with empagliflozin) as compared to vehicle-treated UNx db/db (Fig. 1B) although no differences in body weight were noted between treated and untreated UNx db/db (Fig. 1A). A trend towards ΔGFR decline was observed in UNx db/db treated with empagliflozin and semaglutide on top of RAS blockade (Fig. 1D). Finally, heart weight but not kidney weight was significantly lower in all treated UNx db/db as compared to vehicle-treated UNx db/db (Fig. 1F). Conclusion Our preliminary results show that addition of semaglutide to empagliflozin therapy on top of RAS blockade could have synergic hypoglycemic effects. Further, although more research is needed, both empagliflozin and semaglutide in combination with ramipril trended to ameliorate diabetic hyperfiltration and decreased heart weight in a DN mouse model which suggests cardiorenal beneficial effects.

Xylate effect on the renal toxicological function with diabetes mellitus complicated by endogenous intoxication syndrome of purulent-septic genesis

Use Of Polymyxin B In Patients With Renal Impairment: A Retrospective Examination Of 5 Cases

Evaluation of the use of combined extracorporeal detoxification in patients with severe acute pancreatitis: a retrospective cohort study

THE EFFECTIVENESS OF A COMPREHENSIVE TREATMENT REGIMEN USING SODIUM THIOSULFATE WITH GASTROINTESTINAL DISEASES IN CALVES WITH INTOXICATION SYNDROME

The Effects of a Sodium-Glucose Cotransporter 2 Inhibitor on Diabetic Nephropathy and Serum Oxidized Low-Density Lipoprotein Levels.

Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis

The role of complex metabolic antihypoxants in the treatment of acute drug poisoning in children

Effect of infusion therapy on renal function and laboratory parameters in one-day experiment

931-P: Real-World Study on the Effect of SGLT2 Inhibitors in Patients with Type 2 Diabetes in China

Volume-Independent Sodium Toxicity in Peritoneal Dialysis: New Insights from Bench to Bed

Synthesis and structural characterization of xylan acetate ester and its antinephritic effects in rats with experimental chronic kidney disease

Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Chinese Patients With MDR and XDR Nosocomial Pneumonia

[Intensification of the organism detoxification ability under surgical endogenous intoxication]

#4581 EVALUATION OF THE BENEFICIAL EFFECTS OF SGLT2 INHIBITORS AND GLP-1 RECEPTOR AGONIST ON TOP OF RAS BLOCKADE IN EXPERIMENTAL DIABETIC NEPHROPATHY

Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study

Xanthoceras sorbifolium leaves alleviate hyperuricemic nephropathy by inhibiting the PI3K/AKT signaling pathway to regulate uric acid transport

Effects of combinations of Xiexin decoction constituents on diabetic nephropathy in rats

The effect of enterosgel on the activity of energy supply processes in rats at the same time affected by malathion and tetrachlormethane

Acute Effects of Peritoneal Dialysis Solutions on Appetite in Non-Uremic Rats

A high magnesium concentration in citrate dialysate prevents oxidative stress and damage in human monocytes in vitro

Vancomycin-resistant Enterococcus faecium bacteraemia as a complication of Kayexalate (sodium polystyrene sulfonate, SPS) in sorbitol-induced ischaemic colitis